Mgaywa Gilbert Mjungu Damas Magafu
University of Botswana
21 Papers
30 Citations
Mgaywa Gilbert Mjungu Damas Magafu is an academic researcher from University of Botswana. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 9, co-authored 20 publications. Previous affiliations of Mgaywa Gilbert Mjungu Damas Magafu include University of Washington & Nagasaki University.
Author Tools
Chat about Author
Papers
Maternal risk factors for childhood anaemia in Ethiopia.
Dereje Habte,Kalid Asrat,Mgaywa Gilbert Mjungu Damas Magafu,Ibrahim M Ali,Tadele Melese Benti,Wubeshet Abtew,Girma Tegegne,Dereje Abera,Solomon Shiferaw +8 more
TL;DR: The aim of this study was to explore levels, causes and risk factors associated with maternal mortality in rural Tanzania and found an increased risk of 154% for maternal death for women aged 30-39 versus 15-19 years.
Prophylactic antibiotics to prevent surgical site infections in Botswana: findings and implications.
Julius Chacha Mwita,Sajini Souda,Mgaywa Gilbert Mjungu Damas Magafu,Amos Massele,Brian Godman,Michael Mwandri +5 more
TL;DR: The rate of SSI is a concern, and may be related to inappropriate antibiotic prophylaxis given post operatively, and interventions are in place to decrease SSI rates to acceptable levels in this leading hospital by improving for instance infection prevention practices including the timing of antibiotics.
Non-communicable diseases in antiretroviral therapy recipients in Kagera Tanzania: a cross-sectional study
Mgaywa Gilbert Mjungu Damas Magafu,Kazuhiko Moji,Ehimario U. Igumbor,Naoko Shimizu Magafu,Michael Mwandri,Julius Chacha Mwita,Dereje Habte,Godfrey Mutashambara Rwegerera,Masahiro Hashizume +8 more
TL;DR: Self-reported non-communicable diseases (NCDs) were prevalent among the HAART recipients in Kagera region in Tanzania and their effect on health-related quality of life (HRQOL) was significant.
Incidence of diabetes mellitus‑related comorbidities among patients attending two major HIV clinics in Botswana: a 12‑year retrospective cohort study
Goabaone Rankgoane-Pono,Jose Gaby Tshikuka,Jose Gaby Tshikuka,Mgaywa Gilbert Mjungu Damas Magafu,Mgaywa Gilbert Mjungu Damas Magafu,Tiny Masupe,Mooketsi Molefi,Shimeles Genna Hamda,Vincent Setlhare,Roy Tapera,Bontle Mbongwe +10 more
TL;DR: Data from this study showed that the risk of developing DRCs per year of exposure was significantly greater for patients on first-line compared to those who were on second-, third-line regimen; which, suggests that monitoring of c ART long-term side effects and regular reviewing of cART regimens is important.
SD Bioline malaria antigen Pf (HRP-2/pLHD) for assessing efficacy of artemisinin combination therapy against Plasmodium falciparum in pediatric patients in the Democratic Republic of the Congo.
Albert Lukuka Kilauzi,Jose Gaby Tshikuka Mulumba,Mgaywa Gilbert Mjungu Damas Magafu,Reginald Matchaba-Hove,Roy Tapera,Naoko Shimizu Magafu,Jean Jacques Muyembe Tamfum +6 more
TL;DR: SD Bioline malaria AgPf(HRP-2/pLDH) 3 band Rapid Diagnostic Test (RDT) RDT demonstrated high performance in DRC and can be employed to assess the efficacy of ACT in pediatric malaria patients and prioritize areas that require the deployment of advanced testing like polymerase chain reaction (PCR).